[1]周爱意,周陈静,权彦龙,等.眼内填充在增生型糖尿病视网膜病变合并玻璃体出血玻璃体切割术中的作用[J].眼科新进展,2016,36(9):838-840.[doi:10.13389/j.cnki.rao.2016.0224]
　ZHOU Ai-Yi,ZHOU Chen-Jing,QUAN Yan-Long,et al.Role of intraocular tamponade in vitrectomy for proliferative diabetic retinopathy with vitreous hemorrhage[J].Recent Advances in Ophthalmology,2016,36(9):838-840.[doi:10.13389/j.cnki.rao.2016.0224]
点击复制

眼内填充在增生型糖尿病视网膜病变合并玻璃体出血玻璃体切割术中的作用
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
36卷
期数:
2016年9期
页码:
838-840
栏目:
应用研究
出版日期:
2016-09-05

文章信息/Info

Title:
Role of intraocular tamponade in vitrectomy for proliferative diabetic retinopathy with vitreous hemorrhage
作者:
周爱意; 周陈静; 权彦龙; 王建明
710004　陕西省西安市，西安交通大学第二附属医院眼科
Author(s):
ZHOU Ai-Yi; ZHOU Chen-Jing ;  QUAN Yan-Long ;  WANG Jian-Ming
Department of Ophthalmology, the Second Affiliated Hospital of Medical College of Xi’an Jiaotong University, Xi’ an 710004.Shaanxi Province£®China
关键词:
糖尿病视网膜病变; 玻璃体切割术; 复发性玻璃体出血; 硅油
Keywords:
proliferative diabetic retinopathy ;  vitrectomy;  recurrent vitreous hemorrhage ;  silicone oil
分类号:
Ｒ７７４.１
DOI:
10.13389/j.cnki.rao.2016.0224
文献标志码:
A
摘要:
目的　分析眼内填充在增生型糖尿病视网膜病变（ｐｒｏｌｉｆｅｒａｔｉｖｅｄｉａｂｅｔｉｃｒｅｔｉｎｏｐａｔｈｙ，ＰＤＲ）合并玻璃体出血玻璃体切割术中的作用。方法　回顾性分析２０１３年５月至２０１５年５月西安交通大学第二附属医院眼科收治的ＰＤＲ合并玻璃体出血行玻璃体切割术患者的病例资料。术后随访至少１ａ，记录患者一般资料、术前及术后最佳矫正视力、玻璃体内填充物类型、复发性玻璃体出血和视网膜脱离情况。结果　１３０例（１３０眼）患者分无填充物、空气填充和硅油填充３组分析，其中无填充物组４５例（３４．６％）、空气填充组３５例（２６．９％）和硅油填充组５０例（３８．５％）。三组患者复发性玻璃体出血分别为：１１．１％（５／４５）、８．６％（３／３５）和１０．０％（５／５０）。术后１ａ内，三组分别有９７．８％、９４．３％和９２．０％患者未发生视网膜脱离。结论　ＰＤＲ合并玻璃体出血行玻璃体切割术中应用眼内填充物在减少复发性玻璃体出血和避免视网膜脱离方面并没有优势。术中没有视网膜裂孔时应用眼内填充物是不必要的。
Abstract:
Objective To analyze the role of intraocular tamponade in vitrectomy for proliferative diabetic retinopathy ( PDR) with vitreous hemorrhage. Methods A retrospective analysis of patients who underwent vitrectomy for PDR with vitreous hemorrhage between May 2013 and May 2015 in the department of Ophthalmology, the Second Affiliated Hospital of Medical College of Xi ’ an Jiaotong University was performed. and all patients were followed more than 12 months. The data included age, gender , duration of diabetes , preoperative and postoperative best corrected visual acuity ( BCVA) , type of tamponade ,recurrence of vitreous hemorrhage and retinal detachment were observed. Results A total of 130 eyes of 130 patients were included. The patients were analyzed in three groups :No tamponade group (45 cases.34. 6% ) .air tamponade group ( 35 cases.26. g% ) and silicone oil tamponade group (50 cases ,38. 5% ) . the rate of recurrent vitreous hemorrhage in above three groups were 11. 1% ( 5/45 ) . 8. 6% ( 3/35) and 10. 0% ( 5/50) .and the rate of retinal attachment in postoperative I year were 97. 8% .94. 3% , and 92. 0% , respectively. Conclusion The use of intraocular tamponade in vitrectomy for PDR with vitreous hemorrhage is not found to be superior to no tamponade in reducing recurrent vitreous hemorrhage and avoidance retinal detachment. Therefore .the use of intraocular tamponade in eyes without retinal hole is not beneficial.

相似文献/References:

[1]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[2]董敬远 刘瑶 吴晓艳.玻璃体切割联合白内障手术治疗增生性糖尿病视网膜病变[J].眼科新进展,2012,32(5):000.
[3]张楚 邹玉平 邹秀兰 徐哲 王泳.内窥镜引导玻璃体视网膜手术治疗伴有角膜混浊的外伤性视网膜脱离[J].眼科新进展,2012,32(6):000.
[4]刘刚 马英慧 贾万程.玻璃体切割术联合视网膜光凝或内界膜剥除术治疗黄斑裂孔性视网膜脱离的疗效分析[J].眼科新进展,2012,32(7):000.
[5]刘敬花 李松峰 卢海.23G微创玻璃体切割术在增生性糖尿病视网膜病变治疗中的应用[J].眼科新进展,2012,32(11):000.
[6]王蕊 王兴利 王一.玻璃体切割术治疗球内金属异物并发眼内炎的玻璃体腔填充物的选择[J].眼科新进展,2012,32(11):000.
[7]杨铮 陈彬川 周瑞雅.玻璃体手术后高眼压及其处理[J].眼科新进展,2012,32(11):000.
[8]陈吉婷 李学喜 王志军.两种手术方式取出眼后段磁性异物的对比研究[J].眼科新进展,2012,32(11):000.
[9]张保松.复杂开放性眼外伤手术疗效及其相关影响因素分析[J].眼科新进展,2012,32(12):000.
[10]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[11]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[12]王方 冯乐 惠延年.视网膜光凝和玻璃体手术治疗糖尿病视网膜病变的有效性[J].眼科新进展,2012,32(10):000.
[13]张思伟,柯根杰,顾永昊.有/无填充物微创玻璃体切割术治疗增生性糖尿病视网膜病变合并牵拉性视网膜脱离的疗效比较[J].眼科新进展,2014,34(12):1174.[doi:10.13389/j.cnki.rao.2014.0326]
　ZHANG Si-Wei,KE Gen-Jie,GU Yong-Hao.Efficacy of minimally invasive vitrectomy with/without filler for PDR combined with tractional RD[J].Recent Advances in Ophthalmology,2014,34(9):1174.[doi:10.13389/j.cnki.rao.2014.0326]
[14]冯希敏,祁颖,张凤妍,等.玻璃体内注射雷珠单抗联合玻璃体切割术治疗增生型糖尿病视网膜病变的疗效观察[J].眼科新进展,2016,36(11):1079.[doi:10.13389/j.cnki.rao.2016.0288]
　FENG Xi-Min,QI Ying,ZHANG Feng-Yan,et al.Intravitreal injection of ranibizumab combined with vitrectomy for proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2016,36(9):1079.[doi:10.13389/j.cnki.rao.2016.0288]
[15]尹妮,赵帅,朱红娜.康柏西普预处理联合玻璃体切割术治疗增生型糖尿病视网膜病变[J].眼科新进展,2017,37(8):770.[doi:10.13389/j.cnki.rao.2017.0195]
　YIN Ni,ZHAO Shuai,ZHU Hong-Na.Conbercept pre-treatment combined with vitrectomy for proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2017,37(9):770.[doi:10.13389/j.cnki.rao.2017.0195]
[16]龙婷,陈佳,杜磊,等.雷珠单抗联合玻璃体切割术治疗糖尿病视网膜病变合并新生血管性青光眼[J].眼科新进展,2017,37(12):1182.[doi:10.13389/j.cnki.rao.2017.0298]
　LONG Ting,CHEN Jia,DU Lei,et al.Clinical outcomes of ranibizumab combined with vitrectomy in treatment of patients with diabetic retinopathy accompanied by neovascular glaucoma[J].Recent Advances in Ophthalmology,2017,37(9):1182.[doi:10.13389/j.cnki.rao.2017.0298]
[17]郝琳娜,毕春潮.玻璃体手术前视网膜光凝对增生型糖尿病视网膜病变患者预后的影响[J].眼科新进展,2019,39(2):176.[doi:10.13389/j.cnki.rao.2019.0040]
　HAO Lin-Na,BI Chun-Chao.Effect of laser photocoagulation before vitrectomy on prognosis of patients with proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2019,39(9):176.[doi:10.13389/j.cnki.rao.2019.0040]
[18]王爽,李晓鹏.房水中内皮素-1、超氧化物歧化酶与糖尿病视网膜病变患者术后视力残疾的关系[J].眼科新进展,2023,43(3):203.[doi:10.13389/j.cnki.rao.2023.0041]
　WANG Shuang,LI Xiaopeng.Study on the relationship between endothelin-1, superoxide dismutase in aqueous humor and postoperative visual disability in diabetic retinopathy patients[J].Recent Advances in Ophthalmology,2023,43(9):203.[doi:10.13389/j.cnki.rao.2023.0041]

备注/Memo

备注/Memo:
西安交通大学基金资助（编号：ｘｊｊ２０１４０８０）
更新日期/Last Update: 2016-09-09